A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
Two-centre, open-label, non-randomized, dose-finding phase I study to determine the MTD of E7107 administered by intravenous infusion (as a 2-5 minutes bolus) on days 1, 8 and 15 every 28 days in patients with solid tumors, for whom therapy of proven efficacy does not exist or is not longer effective.
Epistemonikos ID: 62f92d1aa87f69ce6707d21a922b96164afbbabe
First added on: May 04, 2024